UNCY
Unicycive Therapeutics Inc

2,973
Mkt Cap
$92.55M
Volume
1.72M
52W High
$11.00
52W Low
$3.71
PE Ratio
-1.55
UNCY Fundamentals
Price
$4.72
Prev Close
$5.24
Open
$5.30
50D MA
$4.37
Beta
0.83
Avg. Volume
480,788.76
EPS (Annual)
-$5.65
P/B
4.50
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
UNCY Deadline Today: Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ: UNCY) between March...
Business Wire·14d ago
News Placeholder
More News
News Placeholder
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY
Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·15d ago
News Placeholder
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities...
PR Newswire·15d ago
News Placeholder
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY
Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive Therapeutics, Inc. and Certain Officers - UNCY Pomerantz Law Firm Announces the Filing of a Class Action Against Unicycive...
PR Newswire·15d ago
News Placeholder
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive Therapeutics
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Unicycive Therapeutics, Inc. (Unicycive or the Company) (NASDAQ: UNCY) and reminds investors of...
Business Wire·15d ago
News Placeholder
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline
The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics...
PR Newswire·15d ago
News Placeholder
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Unicycive...
PR Newswire·18d ago
News Placeholder
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline UNCY LAWSUIT ALERT: Levi & Korsinsky Notifies Unicycive...
PR Newswire·18d ago
News Placeholder
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking Recovery for Investors - Contact The Gross Law Firm Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) Seeking...
PR Newswire·19d ago
News Placeholder
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit
UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit UNCY Investors have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire...
PR Newswire·20d ago

Latest UNCY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.